van Veggel BAMH, van der Wekken AJ, Paats MS, Hendriks LEL, et al. A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer. Cancer 2023 Oct 31. doi: 10.1002/cncr.35090.
PMID: 37905752